Prospect Financial Group LLC Invests $246,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Prospect Financial Group LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, Holdings Channel.com reports. The fund acquired 486 shares of the healthcare conglomerate’s stock, valued at approximately $246,000.

Other hedge funds have also recently made changes to their positions in the company. Modern Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 5.6% in the fourth quarter. Modern Wealth Management LLC now owns 6,814 shares of the healthcare conglomerate’s stock worth $3,634,000 after buying an additional 363 shares in the last quarter. Segall Bryant & Hamill LLC lifted its holdings in shares of UnitedHealth Group by 2.2% during the 4th quarter. Segall Bryant & Hamill LLC now owns 89,175 shares of the healthcare conglomerate’s stock valued at $45,110,000 after buying an additional 1,956 shares during the period. Taikang Asset Management Hong Kong Co Ltd boosted its position in UnitedHealth Group by 17.2% in the fourth quarter. Taikang Asset Management Hong Kong Co Ltd now owns 17,969 shares of the healthcare conglomerate’s stock worth $9,090,000 after purchasing an additional 2,631 shares during the last quarter. CoreFirst Bank & Trust bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $1,160,000. Finally, ICW Investment Advisors LLC grew its position in shares of UnitedHealth Group by 18.9% during the 4th quarter. ICW Investment Advisors LLC now owns 2,868 shares of the healthcare conglomerate’s stock valued at $1,451,000 after acquiring an additional 455 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 0.0 %

NYSE UNH opened at $516.94 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company’s 50-day simple moving average is $509.71 and its two-hundred day simple moving average is $546.15. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $472.85 billion, a price-to-earnings ratio of 33.35, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.